Biomol Ther.
2023 Jul;31(4):395-401. 10.4062/biomolther.2023.099.
NLRP3 Inflammasome as Therapeutic Targets in Inflammatory Diseases
- Affiliations
-
- 1Department of Pharmacy and Institute of Chronic Disease, Sahmyook University, Seoul 01795, Republic of Korea
- 2Department of Counseling and Psychology, Sahmyook University, Seoul 01795, Republic of Korea
- KMID: 2544061
- DOI: http://doi.org/10.4062/biomolther.2023.099
Abstract
- Innate immunity is a first line defence system in the body which is for sensing signals of danger such as pathogenic microbes or host-derived signals of cellular stress. Pattern recognition receptors (PRR’s), which present in the cell memebrane, are suspect the infection through pathogen-associated molecular patterns (PAMP), and activate innate immunity with response to promote inflammation via inflammatory cells such as macrophages and neutrophils, and cytokines. Inflammasome are protein complexes which are part of innate immunity in inflammation to remove pathogens and repair damaged tissues. What is the important role of inflammation in disease? In this review, we are focused on the action mechanism of NLRP3 inflammasome in inflammatory diseases such as asthma, atopic dermatitis, and sepsis.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The Mechanism of the NLRP3 Inflammasome Activation and Pathogenic Implication in the Pathogenesis of Gout
- Repurposing Auranofin, an Anti-Rheumatic Gold Compound, to Treat Acne Vulgaris by Targeting the NLRP3 Inflammasome
- Loganin Prevents Hepatic Steatosis by Blocking NLRP3 Inflammasome Activation
- NLRP3 Inflammasome and Host Protection against Bacterial Infection
- The Role of NLR-related Protein 3 Inflammasome in Host Defense and Inflammatory Diseases
